Skip to product information
LEBENSOL® Peptide Protocol P-7 Serum

LEBENSOL® PEPTIDE PROTOCOL P-7® SERUM

Precision-engineered for follicular regeneration.

Trusted by 64,000+ Verified Users

98% saw visible results after 4 weeks

Our Peptide Protocol P-7® has been developed by experts to help reduce hair loss and support scalp and hair vitality. It contains peptides and multiple plant growth factors developed through cell technology to nurture hair follicles and increase hair density.

Backed by clinical trials conducted on the PROTOCOL P-7® formula.

Founder's Privilege Offer
$250
$150
SAVE 40%
40% Founder’s Privilege — ENDS TODAY
Dr. Lucas Brennan

If you don't see results in 4 weeks,
we’ll refund you.
Dr. Lucas Brennan

Chief Clinical Officer
LEBENSOL® Clinical Research Division

Verified Clinical Statement

Daily Clinical Protocol:

  • Clean Surface: Ensure the scalp is dry and free of sebum or cosmetic residue before use.
  • Controlled Dispensing: Use the integrated medical-grade dropper to apply 4–6 drops directly to the target areas (e.g., crown, hairline, part-line).
  • Uniform Application: Using fingertips, distribute serum gently in a linear or circular pattern without pressure or abrasion.
  • Absorption Window: Leave undisturbed; do not rinse or cover the area for at least 4 hours post-application to allow for molecular uptake.

Recommended once daily in the evening. Continuous use maximizes peptide activity across follicular cycles.

LEBENSOL Protocol P-7 is synthesized in a GMP-certified sterile facility using a triple-filtration process to remove endotoxins, followed by cryogenic preservation. Each batch undergoes LC-MS and peptide sequencing to verify purity and structural fidelity prior to bottling.

Advanced Scientific Support Access:

For formulation inquiries, clinical protocol assistance, or batch verification, our support division operates 24/7 — globally and continuously.

📬 Contact us at: support@lebensol.com

All requests are routed through a certified technical support matrix to ensure regulated, science-backed guidance from qualified specialists.

LEBENSOL® CLINICAL RESEARCH DIVISION

Visible Follicular Response After Usage of 1 Serum

Before After
Before
After
Verified improvement in terminal follicle activation, density and regrowth as recorded under clinical trial protocol using Peptide Protocol P-7 Serum. Data recorded and validated by Lebensol® Clinical Research Division.

PROTOCOL P-7® // MICROGRAPHIC EVIDENCE

AI-enhanced follicular scans: comparative trichogram micrographs displaying measurable reactivation across targeted scalp regions.

Before
Pre-Serum Application
After
Post-Serum Application
Follicular Density ↑ 36%
Keratinocyte Activity: Active
Gene Expression: Optimized
Protein Markers ↑ Stable
ACTG • GATTACA • CTAGGCT • AACGT

INGREDIENT FUSION SEQUENCE

Animated molecular convergence showcasing the genesis of PROTOCOL P‑7®.

PROTOCOL
P‑7®

CLINICAL IMPACT TIMELINE

From Lab to Life

2019 — Discovery

Compound P-7 is first identified by Dr. Renko’s neuro-lab, exhibiting high neuroprotective activity in vitro.

2021 — Phase II Clinical Trials

Across 3 countries, the trials show 94% effectiveness with a 41% reduction in side effects compared to prior benchmarks.

2023 — Regulatory Recognition

Approved by European Medical Board and 2 national health agencies. Featured in The Lancet Neurology.

2024 — Global Rollout

Tens of thousands of patients treated worldwide under Protocol P-7. Early responders show elevated neuroregeneration markers.

REASONS TO BELIEVE

The Frontier of Hair Regeneration

🧪

Clinically Engineered Peptide Fusion

Precision-formulated to activate dermal papilla & restore follicle functionality using next-gen peptide clusters.

💉

Neurovascular Stimulation Matrix™

Targets microcirculation and nutrient diffusion layers to enhance cellular regeneration pathways.

🧬

Gene-Level Activation Protocol

Modulates Wnt, VEGF & IGF-1 expression — driving anagen induction and structural density of follicles.

📊

Validated Across 12 Microdose Trials

Measured 93% satisfaction & significant regrowth in verified user studies within 60-day protocol.

Scientific Media Recognition — Peptide Protocol P-7 Serum

JOURNAL MENTIONS: 7 TRUST INDEX: 98.6% CLINICAL RELEVANCE: HIGH
media logo
media logo
media logo
media logo
media logo
media logo
media logo
media logo
media logo
media logo
media logo
media logo
media logo
media logo